LabFarm
Updating the operating model
- Biotechnology
- January 2026
A4BEE prepared this analysis from publicly available sources. It reflects our own reading of LabFarm's published strategy and is not endorsed by, or produced in cooperation with, LabFarm. Company website
Strategic priorities
LabFarm operates across 4 stated priorities, with the most concrete near-term plan anchored on industrial scale-up.
Transition from 11L bench-scale bioreactors in Warsaw to 500L-2,000L+ production vessels at the Pionki facility, bridging the "Valley of incident" that bankrupts most cellular agriculture startups through use KPS Food's existing industrial infrastructure.
Execute NCBR grant objectives to develop proprietary serum-free growth media and reduce the 60-80% media cost burden through real-time metabolic monitoring and AI-driven feed rate optimization.
Build submission-ready regulatory dossiers demonstrating cell line genetic stability, absence of adventitious agents, and full compositional analysis with Chain of Identity traceability from Master Cell Bank to final product.
-
01
Industrial Scale-Up
Transition from 11L bench-scale bioreactors in Warsaw to 500L-2,000L+ production vessels at the Pionki facility, bridging the "Valley of incident" that bankrupts most cellular agriculture startups through use KPS Food's existing industrial infrastructure.
-
02
Media Cost Optimization
Execute NCBR grant objectives to develop proprietary serum-free growth media and reduce the 60-80% media cost burden through real-time metabolic monitoring and AI-driven feed rate optimization.
-
03
EFSA Regulatory Pathway
Build submission-ready regulatory dossiers demonstrating cell line genetic stability, absence of adventitious agents, and full compositional analysis with Chain of Identity traceability from Master Cell Bank to final product.
-
04
Brownfield Integration
use KPS Food's existing machine park, distribution chain, and logistics at the Pionki industrial campus to accelerate time-to-market while managing the IT/OT complexity of co-locating pharmaceutical-grade biotech with legacy poultry processing infrastructure.
Challenges we see
- Operations Manufacturing
Volumetric Scaling Physics
LabFarm must scale from 11L bioreactors to 500L-2,000L+ vessels where surface-area-to-volume ratio changes alter the fundamental physics of cell culture. Chicken cells lack cell walls and are highly sensitive to shear stress.
Agitation required for oxygen distribution in large tanks generates shear forces that rupture cells, while gentle stirring leads to oxygen starvation in dead zones—a physics problem without decades of historical data to reference.
- Operations Manufacturing
Growth Media Cost Barrier
Culture media accounts for 60-80% of marginal production cost, containing glucose, amino acids, vitamins, and expensive recombinant growth factors. The NCBR grant explicitly targets proprietary media development.
Reliance on offline sampling introduces hours of latency between metabolic state measurement and feed adjustment, leading to media waste and suboptimal cell growth that directly impacts unit economics.
- Digital Integration
Lab-to-Fab Data Discontinuity
The Warsaw R&D lab uses vendor-specific bioreactor control software from the 2023 RFQ procurement, generating data in proprietary formats. The Pionki production facility will require industrial SCADA systems following ISA-95 standards.
The data structure validating the process in Warsaw will not map to Siemens/Rockwell/Honeywell systems required for the factory, threatening Technology Transfer fidelity and the "Golden Batch" definition.
- Compliance Regulatory
EFSA Data Integrity Requirements
EFSA Novel Food Regulation requires encyclopedic dossiers demonstrating cell line genetic stability, absence of adventitious agents, and full Chain of Identity from Master Cell Bank to final product under the Transparency Regulation (EU) 2019/1381.
Using Excel spreadsheets or paper notebooks—common in early-stage startups—is a fatal flaw for EFSA audit; studies not pre-notified to EFSA are inadmissible regardless of quality.
- Digital Integration
Brownfield IT/OT Complexity
The Pionki facility co-locates with KPS Food's existing poultry processing plant, creating a brownfield environment mixing pharmaceutical-grade biotech requirements with legacy industrial utilities and OT systems.
Connecting precision utility requirements (Water for Injection, cleanroom HVAC) to general industrial utility grids risks cross-contamination of biotech batches from "dirty" utility fluctuations.
Opportunities, by urgency and business impact
Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.
-
Bioprocess Scale-Up Optimization
Empirically determining shear stress and mass transfer parameters for large-scale bioreactors requires expensive, high-risk physical batches. LabFarm lacks the decades of historical data that pharma giants possess.
Digital Twin and CFD simulation can model bioreactor environments in silico, predicting shear gradients and mixing times before committing to physical batch runs, de-risking the "Valley of incident" transition.
-
Media Feed Rate Optimization
Offline sampling creates hours of latency between measuring metabolic state and adjusting feed rates, leading to media waste or metabolite accumulation (lactate, ammonia) that inhibits cell growth.
Process Analytical Technology with AI-driven feedback loops can analyze real-time Raman spectroscopy data to dynamically adjust glucose feed rates, optimizing consumption and directly reducing the 60-80% media cost burden.
-
Technology Transfer Data Continuity
R&D bioreactor software from the 2023 procurement functions as "black boxes" with data trapped in vendor-specific formats, incompatible with industrial S88 batch control and ISA-95 integration standards.
A "Lab-to-Fab" Data Integration Layer can normalize data from diverse R&D controllers and map it to a unified industrial data model, ensuring the "Golden Batch" defined in Warsaw becomes executable in Pionki.
-
Regulatory Data Governance
EFSA requires ALCOA+ compliant data demonstrating that the 2027 product came from a cell line genetically identical to the Master Cell Bank established years prior. Paper notebooks and Excel cannot provide this level of audit-ready integrity.
LIMS implementation with 21 CFR Part 11 compliance ensures every data point generated in Warsaw is submission-ready and tamper-proof, transforming regulation from a "waiting game" to a "data quality game."
-
Brownfield Utility Integration
The Pionki site mixes new high-tech biotech assets requiring state-of-the-art digital networks with legacy KPS Food OT systems for utilities like water and power that may have limited connectivity.
Industrial IoT overlay can monitor shared utilities and create protective data visibility, ensuring biotech batch integrity even when co-located with legacy industrial infrastructure.
What we'd propose
- Digital Lab
Digital Twin for Bioprocess Scale-Up
Computational Fluid Dynamics simulation platform modeling bioreactor environments to predict shear gradients, mixing times, and oxygen distribution patterns before committing to expensive physical batch runs at scale.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital Lab
PAT-Enabled Media Optimization Platform
Process Analytical Technology integration with AI-driven feedback control for real-time metabolic monitoring, enabling dynamic media feed rate optimization to minimize the 60-80% growth media cost burden.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital CDMO
Lab-to-Fab Data Integration Layer
Middleware architecture normalizing data from Warsaw R&D bioreactor controllers and mapping to ISA-95 compliant industrial data models for smooth Technology Transfer to Pionki production systems.
-
OT/IT convergence
DETAIL
-
Batch intelligence
DETAIL
-
Production release flow
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital Lab
Regulatory LIMS Implementation
Laboratory Information Management System with 21 CFR Part 11 compliance enforcing electronic signatures, audit trails, and ALCOA+ data integrity principles for EFSA Novel Food submission readiness.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital CDMO
Brownfield IT/OT Network Architecture
Industrial IoT network design for the Pionki facility integrating pharmaceutical-grade biotech requirements with legacy KPS Food infrastructure while maintaining cybersecurity and utility isolation.
-
OT/IT convergence
DETAIL
-
Batch intelligence
DETAIL
-
Production release flow
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
Digital maturity: today and target
Scored out of 100 across six dimensions. The target is what LabFarm's own published ambition implies — not a perfect score.
- Data Infrastructure 25 → 85
- Fragmented vendor-specific bioreactor software from 2023 RFQ; no unified data model connecting Warsaw lab to future Pionki production
- Process Automation 30 → 90
- 11L bench-scale operations with manual sampling; scaling to 500L+ requires closed-loop PAT control for media optimization
- IT/OT Convergence 20 → 85
- No industrial control systems deployed; greenfield opportunity for proper ISA-95/S88 architecture in Pionki brownfield site
- Analytics & AI 15 → 75
- Empirical parameter determination without historical data; CFD simulation and PAT ML models needed for scale-up de-risking
- Regulatory Compliance 30 → 95
- Pre-EFSA submission phase with likely paper/Excel documentation; 21 CFR Part 11 LIMS required for Novel Food dossier
- Cloud & Security 20 → 80
- R&D lab data locally stored; multi-site architecture needed connecting Warsaw, Pionki, and future regulatory submissions
Check this yourself
Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.
-
Self-assessment
Find Your LIMS
Answer a few questions about your lab and get a shortlist of LIMS that fit it.
-
Self-assessment
Electronic Batch Record (eBR) Readiness
Check how far your batch records are from paperless, and what the next step is.
-
Market comparison
Digital Lab: Equipment & Integration Map
Which lab instruments connect to which systems, and where the gaps usually are.
-
Market comparison
European CDMOs Compared
The 2026 landscape: who does what, at what scale.
Think we've read this right?
Talk to usRelated reading
-
Digital Twin Maturity Model – self-assessment tool
Initially, defining what a digital twin even is seemed simple - we have a real product and its virtual counterpart, and we combine the two.
-
From Paper to Performance: Operational Efficiency and Compliance in Labs
Transform your QC lab with scalable digital solutions that embed compliance, boost efficiency, and deliver a future-ready competitive edge.
-
Don’t let vendor lock-in hold your lab hostage.
How biotech labs avoid vendor lock-in by extending SCADA capabilities with flexible control platforms and multi-vendor integration.
-
13 Imperatives affecting lab modularity digitalization
Introduction A new wave of priorities has emerged in the ever-changing world of laboratories and manufacturing. Modularity, sustainability, scalability, remote access, and cost optimization are no longer just buzzwords; they are essential pillars of success. Laboratories everywhere are on a quest to boost efficiency and cut costs, leading to a skyrocketing demand for modular lab […]
-
OPC UA protocol support in embedded systems
OPC Unified Architecture (OPC UA) is a modern standard for data exchange, increasingly used in industrial environments.
This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with LabFarm, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].